Schrodinger Inc (SDGR) Stock Price, Quote & News

Company Profile

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focu...

Industry: Health Information Services

Sector: Healthcare

Phone: 212 295 5800

Website: www.schrodinger.com

Address:

1540 Broadway, 24th Floor, New York, United States

bambus3001 Aug. 11 at 6:27 PM

$SDGR Sie lassen den Kursanstieg jetzt austrocknen die letzten kurzinvestoren sollen noch den Luxusliner verlassen ,bis dann die Austausch Crew entgültig das Schiff übernimmt und wir eine lange Reise vor uns haben richtung Nordpol .😉

0 · Reply

bambus3001 Aug. 10 at 8:02 PM

$SDGR Lauerstellung Big Player warten zur zeit noch mit grossen Käufen , Viel billiger wirds nicht wieder . 20 steht an und 26 ist mein 1.Ziel jetzt!

0 · Reply

MikeyNJ Aug. 10 at 7:37 PM

$SDGR maybe we should all start speaking German. Seems to be working! Sehr gut!

1 · Reply

bambus3001 Aug. 10 at 10:42 AM

$SDGR Die Zahlen entsprachen meiner Vermutung ,und wir werden langsam den langfristigen Trend Richtung Norden einschlagen Die Firma hat das richtige Thema mit Ki entdeckt ,was noch einen Riesenmarkt erschliessen wird. Big Pharma wird irgendwann eine Übernahme versuchen . Hoffentlich erst bei einer Mk von mindestens 10 Mrd.

0 · Reply

Trader_Ty Aug. 8 at 12:16 PM

$SDGR alert now at 17 ... give us a little pullback

1 · Reply

madnessofcrowds Aug. 7 at 9:32 PM

$SDGR 18 held, now on to 20

0 · Reply

BB_88_ Aug. 7 at 6:23 PM

$SDGR short in to close tight stop

0 · Reply

madnessofcrowds Aug. 6 at 10:01 PM

$SDGR next test is an ~18 hold, then it's back to the 20s.

0 · Reply

bambus3001 Aug. 6 at 7:17 PM

$SDGR Wir bleiben ganz entspannt Und kaufen am besten noch dazu , Es gibt negative Menschen und positiv denkende, Hier heist es realitisch beurteilen .

1 · Reply

BB_88_ Aug. 6 at 6:39 PM

$SDGR close 17.3

0 · Reply

Schrodinger raises FY26 drug discovery revenue view $65M-$75M from $55M-$65M

Aug 5, 2026, 4:30 PM EDT - 7 days ago

Schrödinger Earnings Call Transcript: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 7 days ago

Schrödinger Earnings release: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 7 days ago

Schrödinger Quarterly report: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 7 days ago

Schrödinger Slides: Q2 2026

Aug 5, 2026, 4:05 PM EDT - 7 days ago

Schrödinger Reports Second Quarter 2026 Financial Results

2026-08-05T14:13:22.000Z - 7 days ago

Schrodinger announces collaboration, software agreement with Bristol Myers

BMY

Aug 5, 2026, 8:30 AM EDT - 7 days ago

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

BMY

2026-07-27T11:35:48.000Z - 16 days ago

Schrodinger introduces Bunsen AI co-scientist for molecular discovery

GOOG GOOGL NVDA

Jul 27, 2026, 7:30 AM EDT - 16 days ago

Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery

Jul 22, 2026, 8:30 AM EDT - 21 days ago

Schrödinger to Announce Second Quarter 2026 Financial Results on August 5

2026-07-20T12:40:40.000Z - 23 days ago

Schrodinger reports inducement grants under Nasdaq listing rule

Jul 20, 2026, 8:30 AM EDT - 23 days ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Jun 22, 2026, 12:00 PM EDT - 7 weeks ago

Schrödinger Transcript: AGM 2026

2026-06-18T12:54:39.000Z - 7 weeks ago

Schrodinger reports inducement grants under Nasdaq listing rule

May 19, 2026, 2:05 PM EDT - 3 months ago

Schrödinger Transcript: RBC Capital Markets Global Healthcare Conference 2026

2026-05-14T16:24:26.000Z - 3 months ago

Schrodinger price target lowered to $17 from $19 at Morgan Stanley

May 13, 2026, 5:20 PM EDT - 3 months ago

Schrödinger Transcript: Bank of America Global Healthcare Conference 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Schrödinger Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Schrödinger Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Schrödinger Quarterly report: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Schrödinger Slides: Q1 2026

May 5, 2026, 4:05 PM EDT - 3 months ago

Schrödinger Reports First Quarter 2026 Financial Results

May 4, 2026, 8:30 AM EDT - 3 months ago

Schrödinger to Participate in Upcoming Investor Conferences

Apr 28, 2026, 8:00 AM EDT - 3 months ago

Schrödinger Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 3 months ago

Schrödinger Proxy statement: Proxy filing

Apr 21, 2026, 8:30 AM EDT - 4 months ago

Schrödinger to Announce First Quarter 2026 Financial Results on May 5

2026-04-17T12:52:03.000Z - 4 months ago

Schrodinger reports inducement grants under Nasdaq listing rule

2026-04-13T10:44:45.000Z - 4 months ago

Schrodinger price target lowered to $20 from $25 at KeyBanc

Mar 17, 2026, 9:00 AM EDT - 5 months ago

Schrödinger Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

2026-03-17T12:40:30.000Z - 5 months ago

Schrodinger price target lowered to $13 from $18 at UBS

Mar 10, 2026, 1:40 PM EDT - 5 months ago

Schrödinger Transcript: Leerink Global Healthcare Conference 2026

Mar 3, 2026, 9:50 AM EST - 5 months ago

Schrödinger Transcript: TD Cowen 46th Annual Health Care Conference

2026-02-26T14:49:36.000Z - 5 months ago

Schrodinger price target lowered to $20 from $24 at BofA

2026-02-25T21:49:18.000Z - 6 months ago

Schrodinger reports FY25 EPS ($1.41) vs. ($2.57) last year

Feb 25, 2026, 4:30 PM EST - 6 months ago

Schrödinger Earnings Call Transcript: Q4 2025

Feb 25, 2026, 4:30 PM EST - 6 months ago

Schrödinger Annual report: Q4 2025

Feb 25, 2026, 4:30 PM EST - 6 months ago

Schrödinger Earnings release: Q4 2025

Feb 25, 2026, 4:30 PM EST - 6 months ago

Schrödinger Slides: Q4 2025

Feb 25, 2026, 4:05 PM EST - 6 months ago

Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results

Feb 11, 2026, 8:30 AM EST - 6 months ago

Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25

Jan 12, 2026, 8:30 AM EST - 7 months ago

Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities

2026-01-09T12:13:36.000Z - 7 months ago

Schrodinger announces collaboration with Lilly TuneLab

LLY

Jan 9, 2026, 7:04 AM EST - 7 months ago

Schrodinger to offer Eli Lilly's AI drug discovery platform on its software

LLY

Jan 9, 2026, 7:00 AM EST - 7 months ago

Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign

2026-01-08T14:41:54.000Z - 7 months ago

Schrodinger price target lowered to $24 from $33 at TD Cowen

Nov 19, 2025, 11:00 AM EST - 9 months ago

Schrödinger Transcript: Jefferies London Healthcare Conference 2025

Nov 6, 2025, 8:30 AM EST - 9 months ago

Schrödinger to Present at Jefferies London Healthcare Conference

Nov 5, 2025, 4:30 PM EST - 10 months ago

Schrödinger Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Schrödinger Quarterly report: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Schrödinger Earnings release: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Schrödinger Slides: Q3 2025

Nov 5, 2025, 4:05 PM EST - 10 months ago

Schrödinger Reports Third Quarter 2025 Financial Results

Oct 30, 2025, 7:30 AM EDT - 10 months ago

Copernic Catalysts Announces Achievement of Ammonia Catalyst Milestone in Research Collaboration with Schrödinger

Oct 22, 2025, 8:30 AM EDT - 10 months ago

Schrödinger to Announce Third Quarter 2025 Financial Results on November 5

Sep 8, 2025, 11:30 AM EDT - 1 year ago

Schrödinger Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 27, 2025, 8:30 AM EDT - 1 year ago

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Aug 14, 2025, 7:00 AM EDT - 1 year ago

Schrödinger Announces Discontinuation of SGR-2921 Program

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Quarterly report: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings release: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Slides: Q2 2025

Aug 6, 2025, 4:05 PM EDT - 1 year ago

Schrödinger Reports Second Quarter 2025 Financial Results

Jul 25, 2025, 8:30 AM EDT - 1 year ago

Schrödinger to Announce Second Quarter 2025 Financial Results on August 6

Jul 18, 2025, 10:25 AM EDT - 1 year ago

Material Informatics Company Evaluation Report 2025 | Schrodinger, Dassault Systèmes, and Citrine Informatics Drive Market Growth Through AI, Simulation, and Collaboration

Jul 17, 2025, 8:00 AM EDT - 1 year ago

Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target

$Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia$

Jun 27, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia

Jun 18, 2025, 12:00 PM EDT - 1 year ago

Schrödinger Transcript: AGM 2025

Jun 12, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Transcript: Status Update

Jun 12, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Press release: Status Update

Jun 12, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Slides: Status Update

Jun 12, 2025, 7:00 AM EDT - 1 year ago

Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress

Jun 4, 2025, 1:25 PM EDT - 1 year ago

Schrödinger Transcript: Jefferies Global Healthcare Conference 2025

May 29, 2025, 5:00 PM EDT - 1 year ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer

May 29, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing

May 28, 2025, 12:22 PM EDT - 1 year ago

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

AMGN BIIB DHR GILD IBB ILMN NVS

May 22, 2025, 8:30 AM EDT - 1 year ago

Schrödinger to Present at Jefferies Global Healthcare Conference

May 20, 2025, 6:30 AM EDT - 1 year ago

Schrödinger Announces CFO Appointment

May 14, 2025, 4:40 PM EDT - 1 year ago

Schrödinger Transcript: BofA Securities 2025 Healthcare Conference

May 14, 2025, 9:30 AM EDT - 1 year ago

Schrödinger to Present Phase 1 Clinical Data on MALT1 Inhibitor SGR-1505 at EHA Annual Congress and International Conference on Malignant Lymphoma

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings Call Transcript: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Quarterly report: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings release: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Slides: Q1 2025

May 7, 2025, 4:05 PM EDT - 1 year ago

Schrödinger Reports Strong First Quarter 2025 Financial Results

May 5, 2025, 8:30 AM EDT - 1 year ago

Schrödinger to Present at BofA Securities 2025 Healthcare Conference

bambus3001 Aug. 11 at 6:27 PM

0 · Reply

bambus3001 Aug. 10 at 8:02 PM

$SDGR Lauerstellung Big Player warten zur zeit noch mit grossen Käufen , Viel billiger wirds nicht wieder . 20 steht an und 26 ist mein 1.Ziel jetzt!

0 · Reply

MikeyNJ Aug. 10 at 7:37 PM

$SDGR maybe we should all start speaking German. Seems to be working! Sehr gut!

1 · Reply

bambus3001 Aug. 10 at 10:42 AM

0 · Reply

Trader_Ty Aug. 8 at 12:16 PM

$SDGR alert now at 17 ... give us a little pullback

1 · Reply

madnessofcrowds Aug. 7 at 9:32 PM

$SDGR 18 held, now on to 20

0 · Reply

BB_88_ Aug. 7 at 6:23 PM

$SDGR short in to close tight stop

0 · Reply

madnessofcrowds Aug. 6 at 10:01 PM

$SDGR next test is an ~18 hold, then it's back to the 20s.

0 · Reply

bambus3001 Aug. 6 at 7:17 PM

$SDGR Wir bleiben ganz entspannt Und kaufen am besten noch dazu , Es gibt negative Menschen und positiv denkende, Hier heist es realitisch beurteilen .

1 · Reply

BB_88_ Aug. 6 at 6:39 PM

$SDGR close 17.3

0 · Reply

BB_88_ Aug. 6 at 6:13 PM

$SDGR fade in to close

0 · Reply

BB_88_ Aug. 6 at 5:58 PM

$SDGR resorted 18.32

0 · Reply

madnessofcrowds Aug. 6 at 5:37 PM

$SDGR stop trading this for pennies. buy and hold.

0 · Reply

BB_88_ Aug. 6 at 4:59 PM

$SDGR reshort tight stop

0 · Reply

The_Matrix_reloaded_2020 Aug. 6 at 4:38 PM

$SDGR Sold half I'll watch for now

0 · Reply

bambus3001 Aug. 6 at 2:15 PM

$SDGR Na also geht schon los grosse Pakete zu sammeln ,werden wie immer etwas günstiger angeboten und alle sind zufrieden . Immer wieder das gleiche spielen sie die Big Player !!!

0 · Reply

beatrix19 Aug. 6 at 1:47 PM

$SDGR on my watch-list

0 · Reply

bambus3001 Aug. 6 at 1:46 PM

$SDGR Noch warten die Profis heute mit Käufe,,die Daytrader werden jetzt rausgespühlt und wir starten dann zur 1.Etappe bei 24-26 $

0 · Reply

BB_88_ Aug. 6 at 1:43 PM

$SDGR short 18.27

0 · Reply

Trader_Ty Aug. 6 at 1:34 PM

$SDGR 👀

0 · Reply

dnpro Aug. 6 at 12:27 PM

$SDGR Can it go back to $100S? After great earnings... $QQQ $SPY $TSLA

1 · Reply

bambus3001 Aug. 6 at 11:23 AM

$SDGR Profis haben schon länger kräftig eingesammelt. Da ist sicher eine Fusion oder ein Buyout im Busch .Oder aber grosse Fonds steigen langsam ein . Sehr gut und einfach Genial, was die Firma nachhaltig aufbaut .

1 · Reply

Market Cap	1.38B
Revenue (ttm)	255.87M
Net Income (ttm)	-103.27M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-40.36%
Debt to Equity Ratio	0.00

Volume	1,476,700
Avg Vol	1,265,132
Day's Range	N/A - N/A
Shares Out	73.83M
Stochastic %K	86%
Beta	1.63
Analysts	Strong Sell
Price Target	$20.57